Navigation Links
Reportlinker Adds The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 - Strategies to Counter Generic Erosion in Key Markets
Date:6/1/2010

py ($), 2009-2016 97

Table 115:Ophthalmology Therapeutics Market, Japan, Treatment Usage Patterns, 2001-2009 98

Table 116:Ophthalmology Therapeutics Market, Japan, Treatment Usage Patterns, 2009-2016 99

Table 117:Ophthalmology Therapeutics Market, Japan, Diseased Population (Millions), 2001-2009 100

Table 118:Ophthalmology Therapeutics Market, Japan, Diseased Population (Millions), 2009-2016 100

Table 119:Ophthalmology Therapeutics Market, Japan, Treatment Seeking Population (Millions), 2001-2009 101

Table 120: Ophthalmology Therapeutics Market, Japan, Treatment Seeking Population (Millions), 2009-2016 101

Table 121:Ophthalmology Therapeutics Market, Japan, Diagnosed Population (Millions), 2001-2009 102

Table 122:Ophthalmology Therapeutics Market, Japan, Diagnosed Population (Millions), 2001-2016 102

Table 123:Ophthalmology Therapeutics Market, Japan, Prescription Population (Millions), 2001-2009 103

Table 124:Ophthalmology Therapeutics Market, Japan, Prescription Population (Millions), 2009-2016 103

Table 125:Ophthalmology Therapeutics Market, Pfizer, Pipeline Products, 2010 116

Table 126:Ophthalmology Therapeutics Market, Allergan, Pipeline Products, 2010 118

Table 127:Ophthalmology Therapeutics Market, Alcon, Pipeline Products, 201
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 2015   HeartWare International, Inc . (NASDAQ: HTWR ... technologies that are revolutionizing the treatment of advanced heart failure, ... is scheduled to present at the Bank of America Merrill ... on Thursday, May 14, 2015, at 10:00 a.m. ... the Company,s presentation at the conference will be available via ...
(Date:5/4/2015)... May 4, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ... with Bayer HealthCare (Bayer) to develop and commercialize ISIS-FXI ... terms of the agreement, Isis is eligible to receive ... immediate $100 million up-front payment and a $55 million ... 2 study in patients with compromised kidney function. Isis ...
(Date:5/4/2015)... DIEGO , May 4, 2015 ... oncology company focused on the clinical development of ... data showing mitochondria-specific effects of the Company,s investigational ... enhanced anti-tumor activity when combined with a tyrosine-kinase ... found ME-344 to be a potent inhibitor of ...
Breaking Medicine Technology:HeartWare Presentation At Bank Of America Merrill Lynch 2015 Health Care Conference To Be Webcast 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 4Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 5MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 2MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 3MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 4MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 5
... Inc. (NYSE Amex: ANX ) today announced that ... at the 10th Annual BIOInvestor Forum Conference on Wednesday, October ... Cliff Salon at the Palace Hotel in San Francisco. ... and slide presentation on the ADVENTRX Pharmaceuticals web site at ...
... Innocoll, Inc. announced it has entered into a ... for CollaGUARD surgical adhesion barrier for the prevention of ... Dr. Michael Myers, President and CEO stated "This ... an increasingly important and dynamic market for medical products ...
Cached Medicine Technology:Innocoll Enters Partnership With Pioneer Pharma in China for the Distribution of CollaGUARD 2Innocoll Enters Partnership With Pioneer Pharma in China for the Distribution of CollaGUARD 3
(Date:5/4/2015)... 05, 2015 The National Association ... Betancourt as a 2015-2016 inductee into the NAPW ... with this prestigious distinction for leadership in business. NAPW ... women, boasting more than 700,000 members and over 200 ... with this important honor," said NAPW President Star Jones. ...
(Date:5/4/2015)... Every Friday afternoon at A Forever ... Southwest Michigan, patients and staff gather in the common ... rehabilitation program and to gain encouragement and inspiration in ... One by one, those patients who have completed their ... certificates and to share a bit about their journey ...
(Date:5/4/2015)... Montreal, CANADA (PRWEB) May 04, 2015 ... development of innovative proofreading technologies, today announced that ... #438 at the Music City Center, in Nashville ... Proofware is the world's first true all-in-one we-based ... everyone involved in the security of their brand ...
(Date:5/4/2015)... City, MO (PRWEB) May 04, 2015 ... vice president and chief physician executive, and William C. ... have received and accepted personal invitations from the Secretary ... National Security Forum (NSF) at the Air War College, ... is to expose influential citizens to senior U.S. and ...
(Date:5/4/2015)... Milton Hershey School® has named J. ... the Year, recognizing his commitment to pediatric cancer research ... for MHS students. , “Dr. Graves is a tremendous ... are provided a top-notch education, a nurturing environment, and ... Pete Gurt ’85, president of MHS. “He is applying ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Gloria Betancourt, Receptionist at Consulate Health Care, into its 2015-2016 VIP Woman of the Year Circle 2Health News:A Forever Recovery Celebrates New Victories in Overcoming Addiction With Weekly Graduation 2Health News:Global Vision to Spotlight Proofware at INFO*FLEX 2015 2Health News:Saint Luke’s Health System Leadership Selected to Attend National Security Forum 2Health News:Milton Hershey School Names 2015 Alumnus of the Year 2
... Enjoy Broad Choice of,Prescription Drugs, WASHINGTON, Jan. 31 ... statement on new budget,figures that report the cost of ... years than was estimated last summer:, "Part D ... drugs. New budget documents show that the overall,projected cost ...
... 2008. As part of its ongoing efforts to do ... and a cure for Parkinson,s disease, The Michael J. ... $3 million in total funding to four industry teams ... the clinic. The awards were granted under MJFF,s Therapeutics ...
... Schering-Plough,Corporation (NYSE: SGP ) today reported ... received an A-1 recommendation(1) (highest,rating) for the ... risk patients in the latest Treatment of ... Society of America (IDSA),released this month. The ...
... Jan. 31 Cardinal Health, a,global provider of products ... care, today announced the resignation of Matthew D.,Walter from ... quarterly dividend., "We want to thank Matt for ... John B. McCoy, chairman of the Nominating and,Governance Committee. ...
... Jan. 31 National opinion leaders will,convene in ... latest data,guidelines, practical applications, and strategies for the ... to make the,meeting highly interactive., The Summit ... credits sponsored,by The Dannemiller Educational Foundation, and the ...
... a gene that is the key switch that allows ... Much like students in a kindergarten class lining up ... identified as Smarcd3, must align correctly with two other ... as myogenesis, said principal investigator Monte Westerfield, a professor ...
Cached Medicine News:Health News:Michael J. Fox Foundation awards up to $3 million to industry teams 2Health News:Michael J. Fox Foundation awards up to $3 million to industry teams 3Health News:New IDSA Clinical Practice Guidelines Recommend NOXAFIL(R) (Posaconazole) for Antifungal Prophylaxis in Certain High-Risk Patients 2Health News:New IDSA Clinical Practice Guidelines Recommend NOXAFIL(R) (Posaconazole) for Antifungal Prophylaxis in Certain High-Risk Patients 3Health News:New IDSA Clinical Practice Guidelines Recommend NOXAFIL(R) (Posaconazole) for Antifungal Prophylaxis in Certain High-Risk Patients 4Health News:New IDSA Clinical Practice Guidelines Recommend NOXAFIL(R) (Posaconazole) for Antifungal Prophylaxis in Certain High-Risk Patients 5Health News:New IDSA Clinical Practice Guidelines Recommend NOXAFIL(R) (Posaconazole) for Antifungal Prophylaxis in Certain High-Risk Patients 6Health News:Cardinal Health Announces Resignation of Director; Declares Regular Quarterly Dividend 2Health News:Dannemiller Memorial Education Foundation and GR MedEd, Inc. Announce Oncology Summit: From Discovery to Delivery 2Health News:Dannemiller Memorial Education Foundation and GR MedEd, Inc. Announce Oncology Summit: From Discovery to Delivery 3Health News:Oregon researchers find trigger gene for muscle development 2
... medication nebulizer achieves optimum lung penetration for ... range is 1.04-1.10 µ at 6-8 LPM. ... outlet., ,As the world leader in ... the assurance of proven technology by offering ...
... breakthrough continuous low-flow nebulizer performance. Patented ... technology allows for optimal medication and ... Heliox). OMNI~NEB takes on severe asthma, ... and critical care situations. Configure with ...
... offer a spill-proof design and effective output, ... angle. All medical nebulizers are free-standing for ... configurations are available., ,All Portex® medication ... medication nebulizers feature consistently fine misting and ...
... a spill-proof design and effective output, even ... All medical nebulizers are free-standing for easy ... are available., ,All Portex® medication nebulizer ... nebulizers feature consistently fine misting and the ...
Medicine Products: